Literature DB >> 25122564

Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins.

Leonid Kagan1.   

Abstract

Subcutaneous injection is an important route of administration for therapeutic proteins that provides several advantages over other modes of parenteral delivery. Despite extensive clinical use, the exact mechanism underlying subcutaneous absorption of proteins is not completely understood, and the accuracy of prediction of absorption of biotherapeutics in humans remains unsatisfactory. This review summarizes a variety of models that have been developed for describing the pharmacokinetics of therapeutic proteins administered by subcutaneous injection, including single- and dual-pathway absorption models. Modeling of the lymphatic uptake and redistribution, absorption of monoclonal antibodies and insulin, and population analysis of protein absorption are discussed. The review also addresses interspecies modeling and prediction of absorption in humans, highlights important factors affecting the absorption processes, and suggests approaches for future development of mechanism-based absorption models.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122564     DOI: 10.1124/dmd.114.059121

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  21 in total

1.  The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment.

Authors:  Ding Li; Stacey D Finley
Journal:  Integr Biol (Camb)       Date:  2018-04-23       Impact factor: 2.192

Review 2.  Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration.

Authors:  Ninad Varkhede; Rupesh Bommana; Christian Schöneich; M Laird Forrest
Journal:  J Pharm Sci       Date:  2019-08-10       Impact factor: 3.534

3.  Capacity limits of asialoglycoprotein receptor-mediated liver targeting.

Authors:  Charlotte Bon; Thomas Hofer; Alain Bousquet-Mélou; Mark R Davies; Ben-Fillippo Krippendorff
Journal:  MAbs       Date:  2017-09-06       Impact factor: 5.857

4.  A distributed delay approach for modeling delayed outcomes in pharmacokinetics and pharmacodynamics studies.

Authors:  Shuhua Hu; Michael Dunlavey; Serge Guzy; Nathan Teuscher
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-01-24       Impact factor: 2.745

5.  Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation.

Authors:  John C Kraft; Lisa A McConnachie; Josefin Koehn; Loren Kinman; Jianguo Sun; Ann C Collier; Carol Collins; Danny D Shen; Rodney J Y Ho
Journal:  J Control Release       Date:  2018-02-10       Impact factor: 9.776

6.  Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease.

Authors:  Changrim Lee; Hao Guo; Wannita Klinngam; Srikanth R Janga; Frances Yarber; Santosh Peddi; Maria C Edman; Nishant Tiwari; Siyu Liu; Stan G Louie; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  Mol Pharm       Date:  2019-05-30       Impact factor: 4.939

7.  Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to Humans.

Authors:  Wolfgang F Richter; Hans-Peter Grimm; Marie-Hélène Gouy; Susi Søgaard; Caroline Kreuzer; Uwe Wessels; Dragomir Draganov; Chris Muenzer; Tonio Hoche
Journal:  AAPS J       Date:  2020-04-03       Impact factor: 4.009

Review 8.  Key Physicochemical Characteristics Influencing ADME Properties of Therapeutic Proteins.

Authors:  Xing Jing; Yan Hou; William Hallett; Chandrahas G Sahajwalla; Ping Ji
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  The effects of arginine glutamate, a promising excipient for protein formulation, on cell viability: Comparisons with NaCl.

Authors:  Priscilla Kheddo; Alexander P Golovanov; Kieran T Mellody; Shahid Uddin; Christopher F van der Walle; Rebecca J Dearman
Journal:  Toxicol In Vitro       Date:  2016-02-10       Impact factor: 3.500

10.  A Tutorial on Target-Mediated Drug Disposition (TMDD) Models.

Authors:  P Dua; E Hawkins; P H van der Graaf
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.